Where is Nuvectra located?

Nuvectra is headquartered in Plano, United States.

How many employees does Nuvectra have?

As of May 31, 2026, the latest employee count at Nuvectra is 19.

Is Nuvectra a funded company?

Nuvectra is a funded company, having raised a total of $***** in its 1st and only funding round.

What is the annual revenue of Nuvectra?

Annual revenue of Nuvectra is between $10M and $50M as on Dec 31, 2018

Where does Nuvectra rank among its competitors?

Nuvectra ranks 3rd amongst 34 active competitors, of which 4 are funded. It stands 6th in terms of total funding among its competitors. The most recent competitor to raise funding was Saluda Medical, which secured $30M in Oct, 2025.

Who are the top competitors of Nuvectra?

Nuvectra's top competitors include Nalu Medical, Saluda Medical and Biowave. Among them, Saluda Medical secured the most recent funding round in October, 2025.

Nuvectra - 2026 Company Profile, Competitors & Financials

Nuvectra is a public company based in Plano (United States), founded in 2016. It operates as a Spinal cord stimulation system for treating of chronic pain of the trunk and/or limbs. The company has 34 active competitors, including 4 funded and 5 that have exited. Its top competitors include companies like Nalu Medical, Saluda Medical and Biowave.

Company Details

Nuvectra (spin off from Greatbatch) is developing neurostimulation devices for people suffering from chronic neurological conditions. They have developed a CE marked and FDA approved Algovita Spinal Cord Stimulation system for treating chronic pain in the trunk and/or limbs, and other neurological indications such as sacral nerve stimulation (SNS), and deep brain stimulation (DBS). In addition, their NeuroNexus subsidiary designs manufacture and market neural-interface technologies for the neuroscience clinical research market.

Key Metrics

Founded Year

2016

Location

Plano, United States

Stage

Public

Ranked

3^rd among 34 active competitors

Annual Revenue

$10M - $50M as on Dec 31, 2018

Employee Count

19 as on May 31, 2026

Similar Companies

Nalu Medical & 52 more

Exit Details

Public

View Nuvectra's full profile

Nuvectra is associated with 1 legal entity given below:

Legal Entity Name	Date of Incorporation	Revenue	Latest Employee Count	Documents
NUVECTRA CORP CIN: 1648893 , United States, Active	Nov 13, 2008	$10M - $50M (As on Dec 31, 2018)	200 (As on Dec 31, 2018)	-

Nuvectra got listed on Mar 18, 2016.

Click here to take a look at Nuvectra's IPO in detail

Nuvectra is a funded company.

Nuvectra's employee count trend

Nuvectra has 19 employees as of May 26. Here is Nuvectra's employee count trend over the years:

Uncover Nuvectra's growth story! Sign up today!

Access Tracxn on any website

Our Google Chrome extension lets you view company details while browsing their websites

Install Tracxn Extension

Top competitors of Nuvectra include Nalu Medical, Saluda Medical and Biowave. Here is the list of Top 10 competitors of Nuvectra, ranked by Tracxn score:

Rank	Company Details	Short Description	Total Funding	Investors	Tracxn Score
1st	Nalu Medical 2014, Carlsbad (United States), Acquired	Developer of a neurostimulation system for managing intractable chronic pain	$231M	MVM, Gilde Healthcare & 9 others	67/100
2nd	Saluda Medical 2010, Bloomington (United States), Public	Developer of neuromodulation platform measuring biomarkers for chronic neurological condition treatment	$530M	Redmile Group, Wellington & 9 others	66/100
3rd	Nuvectra 2016, Plano (United States), Public	Spinal cord stimulation system for treating of chronic pain of the trunk and/or limbs	-	-	43/100
4th	Biowave 2000, Norwalk (United States), Seed	Innovative pain relief solutions using neurostimulation technology for athletes and chronic pain sufferers	$2.08M	Connecticut Innovations	40/100
5th	Calmare Therapeutics 1968, Fairfield (United States), Funding Raised	Develops devices for the treatment of chronic and neuropathic pain	-	-	34/100
6th	SzeleSTIM 2015, Vienna (Austria), Funding Raised	Developer of smart products for pain treatment	-	EIC Fund, Europa & 1 others	34/100
7th	Stimwave 2010, Pompano Beach (United States), Deadpooled	Developer of smart devices for neuropathic pain monitoring	$9.78M	Prettybrook Partners, Foothill Ventures	34/100
8th	Alpha-Stim 1996, Texas City (United States), Acquired	Develops a non-drug treatment for pain	-	-	32/100
9th	SOLO-DEX 2016, Bozeman (United States), Funding Raised	Developer of a device for peripheral nerve block procedure	-	-	32/100
10th	StimAire 2018, Tucson (United States), Seed	Developer of neural stimulation treatment therapy	$1.56M	UAVenture Capital Fund	30/100